Abstract
Altered levels of human plasma metabolites have been implicated in the etiology of bipolar disorder (BD). However, the causality between metabolites and the disease was not well described. We performed a bidirectional metabolome-wide Mendelian randomization (MR) analysis to evaluate the potential causal relationships between 871 plasma metabolites and BD. We used DrugBank and ChEMBL to evaluate whether related metabolites are potential therapeutic targets. Finally, Bayesian colocalization analysis was performed to identify shared genomic loci BD and identified metabolites. Our MR results showed that six metabolites were significantly associated with a reduced risk of BD, including arachidonate (20:4n6) (OR: 0.90, 95% CI: 0.84–0.95) and sphingomyelin (d18:2/24:1, d18:1/24:2) (OR: 0.92, 95% CI: 0.87–0.96), while five metabolites were significantly associated with an increased risk of BD, including 1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) (OR: 1.09, 95% CI: 1.05–1.13). However, our reverse MR analysis showed that BD was not associated with the levels of any metabolite. Additionally, the leave-one-out analysis revealed SNPs within chromosome 11 loci harboring MYRF, FADS1, and FADS2 as ones with the potential to influence partial causal effects. Druggability evaluation showed that 10 of the BD-related metabolites, such as sphingomyelin and cytidine, have been targeted by pharmacologic intervention. Colocalization analysis highlighted one colocalized region (chromosome 11q12) shared by 11 metabolites and BD and pointed to some genes as possible players, including FADS1, FADS2, FADS3, and SYT7. Our study supported a causal role of plasma metabolites in the susceptibility to BD, and the identified metabolites may provide a new avenue for the prevention and treatment of BD.
Access through your institution
Buy or subscribe
This is a preview of subscription content, access via your institution
Access options
Access through your institution
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Learn more
Buy this article
Purchase on SpringerLink
Instant access to full article PDF
Buy now
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Log in
Learn about institutional subscriptions
Read our FAQs
Contact customer support
Fig. 1: Flowchart of the study.
Fig. 2: Forest plot of causal effects of plasma metabolites on BD (FDR < 0.05).
Fig. 3: Forest plot of causal effects of BD on plasma metabolites (P < 0.05).
Fig. 4: Druggability of plasma metabolites with a causal effect on BD.
Fig. 5: One colocalized region between metabolites and BD.
Data availability
All data generated or analyzed during this study are included in this published article and its supplementary information files.
References
Vieta E, Berk M, Schulze TG, Carvalho AF, Suppes T, Calabrese JR, et al. Bipolar disorders. Nat Rev Dis Primers. 2018;4:18008.
PubMedGoogle Scholar
Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68:241–51.
PubMedPubMed CentralGoogle Scholar
Plans L, Barrot C, Nieto E, Rios J, Schulze TG, Papiol S, et al. Association between completed suicide and bipolar disorder: A systematic review of the literature. J Affect Disord. 2019;242:111–22.
CASPubMedGoogle Scholar
Vigo D, Thornicroft G, Atun R. Estimating the true global burden of mental illness. Lancet Psychiatry. 2016;3:171–8.
PubMedGoogle Scholar
Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet Part C, Semin Med Genet. 2003;123c:48–58.
PubMedGoogle Scholar
Baker SA, Rutter J. Metabolites as signalling molecules. Nat Rev Mol Cell Biol. 2023;24:355–74.
CASPubMedGoogle Scholar
Shin SY, Fauman EB, Petersen AK, Krumsiek J, Santos R, Huang J, et al. An atlas of genetic influences on human blood metabolites. Nat Genet. 2014;46:543–50.
CASPubMedPubMed CentralGoogle Scholar
Chen Y, Lu T, Pettersson-Kymmer U, Stewart ID, Butler-Laporte G, Nakanishi T, et al. Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. Nat Genet. 2023;55:44–53.
PubMedPubMed CentralGoogle Scholar
Wishart DS. Metabolomics for investigating physiological and pathophysiological processes. Physiol Rev. 2019;99:1819–75.
CASPubMedGoogle Scholar
Bartel J, Krumsiek J, Schramm K, Adamski J, Gieger C, Herder C, et al. The human blood metabolome-transcriptome interface. PLoS Genet. 2015;11:e1005274.
PubMedPubMed CentralGoogle Scholar
Bartoli F, Cioni RM, Cavaleri D, Callovini T, Crocamo C, Misiak B, et al. The association of kynurenine pathway metabolites with symptom severity and clinical features of bipolar disorder: an overview. Eur Psychiatry. 2022;65:e82.
PubMedPubMed CentralGoogle Scholar
Ribeiro HC, Sen P, Dickens A, Santa Cruz EC, Orešič M, Sussulini A. Metabolomic and proteomic profiling in bipolar disorder patients revealed potential molecular signatures related to hemostasis. Metabolomics. 2022;18:65.
CASPubMedGoogle Scholar
Lan MJ, McLoughlin GA, Griffin JL, Tsang TM, Huang JT, Yuan P, et al. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Mol Psychiatry. 2009;14:269–79.
CASPubMedGoogle Scholar
Kageyama Y, Kasahara T, Morishita H, Mataga N, Deguchi Y, Tani M, et al. Search for plasma biomarkers in drug-free patients with bipolar disorder and schizophrenia using metabolome analysis. Psychiatry Clin Neurosci. 2017;71:115–23.
CASPubMedGoogle Scholar
Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27:1133–63.
PubMedGoogle Scholar
Chen F, Cao H, Baranova A, Zhao Q, Zhang F. Causal associations between COVID-19 and childhood mental disorders. BMC Psychiatry. 2023;23:922.
CASPubMedPubMed CentralGoogle Scholar
Baranova A, Chandhoke V, Cao H, Zhang F. Shared genetics and bidirectional causal relationships between type 2 diabetes and attention-deficit/hyperactivity disorder. Gen Psychiatry. 2023;36:e100996.
CASGoogle Scholar
Baranova A, Zhao Q, Cao H, Chandhoke V, Zhang F. Causal influences of neuropsychiatric disorders on Alzheimer’s disease. Transl Psychiatry. 2024;14:114.
PubMedPubMed CentralGoogle Scholar
Zhang L, Yang F, Ma J, Hu Y, Li M, Wang C, et al. The impact of testosterone on Alzheimer’s disease are mediated by lipid metabolism and obesity: a mendelian randomization study. J Prev Alzheimer’s Dis. 2024;11:507–13.
CASGoogle Scholar
Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.
PubMedPubMed CentralGoogle Scholar
Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10:e1004383.
PubMedPubMed CentralGoogle Scholar
Mullins N, Forstner AJ, O’Connell KS, Coombes B, Coleman JRI, Qiao Z, et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 2021;53:817–29.
CASPubMedPubMed CentralGoogle Scholar
Emdin CA, Khera AV, Kathiresan S. Mendelian Randomization. JAMA. 2017;318:1925–6.
PubMedGoogle Scholar
Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512–25.
PubMedPubMed CentralGoogle Scholar
Bowden J, Del Greco MF, Minelli C, Zhao Q, Lawlor DA, Sheehan NA, et al. Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption. Int J Epidemiol. 2019;48:728–42.
PubMedGoogle Scholar
Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40:755–64.
PubMedGoogle Scholar
Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46:D1074–d82.
CASPubMedGoogle Scholar
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, et al. ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res. 2019;47:D930–d40.
CASPubMedGoogle Scholar
Wallace C. Eliciting priors and relaxing the single causal variant assumption in colocalisation analyses. PLoS Genet. 2020;16:e1008720.
CASPubMedPubMed CentralGoogle Scholar
Wei J, Zhao L, Du Y, Tian Y, Ni P, Ni R, et al. A plasma metabolomics study suggests alteration of multiple metabolic pathways in patients with bipolar disorder. Psychiatry Res. 2021;299:113880.
CASPubMedGoogle Scholar
Kasahara T, Takata A, Kato TM, Kubota-Sakashita M, Sawada T, Kakita A, et al. Depression-like episodes in mice harboring mtDNA deletions in paraventricular thalamus. Mol Psychiatry. 2016;21:39–48.
CASPubMedGoogle Scholar
Gaebel W, Zielasek J. Schizophrenia in 2020: Trends in diagnosis and therapy. Psychiatry Clin Neurosci. 2015;69:661–73.
PubMedGoogle Scholar
Cho DH, Park JH, Joo Lee E, Jong Won K, Lee SH, Kim YH, et al. Valproic acid increases NO production via the SH-PTP1-CDK5-eNOS-Ser(116) signaling cascade in endothelial cells and mice. Free Radic Biol Med. 2014;76:96–106.
CASPubMedGoogle Scholar
Feinstein DL. Potentiation of astroglial nitric oxide synthase type-2 expression by lithium chloride. J Neurochem. 1998;71:883–6.
CASPubMedGoogle Scholar
Yokoyama S, Yasui-Furukori N, Nakagami T, Miyazaki K, Ishioka M, Tarakita N, et al. Association between the serum carnitine level and ammonia and valproic acid levels in patients with bipolar disorder. Therapeutic Drug Monit. 2020;42:766–70.
CASGoogle Scholar
Kadriu B, Farmer CA, Yuan P, Park LT, Deng ZD, Moaddel R, et al. The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response. Mol Psychiatry. 2021;26:4085–95.
PubMedGoogle Scholar
Claes S, Myint AM, Domschke K, Del-Favero J, Entrich K, Engelborghs S, et al. The kynurenine pathway in major depression: haplotype analysis of three related functional candidate genes. Psychiatry Res. 2011;188:355–60.
CASPubMedGoogle Scholar
Lavebratt C, Olsson S, Backlund L, Frisén L, Sellgren C, Priebe L, et al. The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression. Mol Psychiatry. 2014;19:334–41.
CASPubMedGoogle Scholar
Pramod AB, Foster J, Carvelli L, Henry LK. SLC6 transporters: structure, function, regulation, disease association and therapeutics. Mol Asp Med. 2013;34:197–219.
CASGoogle Scholar
Mazei-Robison MS, Couch RS, Shelton RC, Stein MA, Blakely RD. Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder. Neuropharmacology. 2005;49:724–36.
CASPubMedGoogle Scholar
Rapoport SI, Basselin M, Kim HW, Rao JS. Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev. 2009;61:185–209.
CASPubMedPubMed CentralGoogle Scholar
Rapoport SI. Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade. ACS Chem Neurosci. 2014;5:459–67.
CASPubMedPubMed CentralGoogle Scholar
Cheon Y, Park JY, Modi HR, Kim HW, Lee HJ, Chang L, et al. Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E2 concentration in rat brain. J Neurochem. 2011;119:364–76.
CASPubMedPubMed CentralGoogle Scholar
Lee HJ, Ghelardoni S, Chang L, Bosetti F, Rapoport SI, Bazinet RP. Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat. Neurochem Res. 2005;30:677–83.
CASPubMedGoogle Scholar
Gracia-Garcia P, Rao V, Haughey NJ, Bandaru VV, Smith G, Rosenberg PB, et al. Elevated plasma ceramides in depression. J Neuropsychiatry Clin Neurosci. 2011;23:215–8.
CASPubMedPubMed CentralGoogle Scholar
Gulbins E, Palmada M, Reichel M, Lüth A, Böhmer C, Amato D, et al. Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs. Nat Med. 2013;19:934–8.
CASPubMedGoogle Scholar
Kornhuber J, Müller CP, Becker KA, Reichel M, Gulbins E. The ceramide system as a novel antidepressant target. Trends Pharmacol Sci. 2014;35:293–304.
CASPubMedGoogle Scholar
Gabandé-Rodríguez E, Boya P, Labrador V, Dotti CG, Ledesma MD. High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A. Cell Death Differ. 2014;21:864–75.
PubMedPubMed CentralGoogle Scholar
Keam SJ. Olipudase alfa: first approval. Drugs. 2022;82:941–7.
CASPubMedGoogle Scholar
McCormack PL, Goa KL. Miglustat. Drugs. 2003;63:2427–34.
CASPubMedGoogle Scholar
Vykoukal J, Fahrmann JF, Gregg JR, Tang Z, Basourakos S, Irajizad E, et al. Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer. Nat Commun. 2020;11:4279.
CASPubMedPubMed CentralGoogle Scholar
Ikeda M, Takahashi A, Kamatani Y, Okahisa Y, Kunugi H, Mori N, et al. A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder. Mol Psychiatry. 2018;23:639–47.
CASPubMedGoogle Scholar
Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat Genet. 2019;51:793–803.
CASPubMedPubMed CentralGoogle Scholar
Yamamoto H, Lee-Okada HC, Ikeda M, Nakamura T, Saito T, Takata A, et al. GWAS-identified bipolar disorder risk allele in the FADS1/2 gene region links mood episodes and unsaturated fatty acid metabolism in mutant mice. Mol Psychiatry. 2023;28:2848–56.
CASPubMedPubMed CentralGoogle Scholar
Stacey D, Benyamin B, Lee SH, Hyppönen E. A metabolome-wide mendelian randomization study identifies dysregulated arachidonic acid synthesis as a potential causal risk factor for bipolar disorder. Biol Psychiatry. 2024;96:455–62.
CASPubMedGoogle Scholar
Kaeser PS, Regehr WG. Molecular mechanisms for synchronous, asynchronous, and spontaneous neurotransmitter release. Annu Rev Physiol. 2014;76:333–63.
CASPubMedGoogle Scholar
Bhalla A, Tucker WC, Chapman ER. Synaptotagmin isoforms couple distinct ranges of Ca2+, Ba2+, and Sr2+ concentration to SNARE-mediated membrane fusion. Mol Biol Cell. 2005;16:4755–64.
CASPubMedPubMed CentralGoogle Scholar
Shen W, Wang QW, Liu YN, Marchetto MC, Linker S, Lu SY, et al. Synaptotagmin-7 is a key factor for bipolar-like behavioral abnormalities in mice. Proc Natl Acad Sci USA. 2020;117:4392–9.
CASPubMedPubMed CentralGoogle Scholar
Bertolino A, Frye M, Callicott JH, Mattay VS, Rakow R, Shelton-Repella J, et al. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry. 2003;53:906–13.
PubMedGoogle Scholar
Wang QW, Wang YH, Wang B, Chen Y, Lu SY, Yao J. Synaptotagmin-7-mediated activation of spontaneous NMDAR currents is disrupted in bipolar disorder susceptibility variants. PLoS Biol. 2021;19:e3001323.
CASPubMedPubMed CentralGoogle Scholar
Keogh CE, Kim DHJ, Pusceddu MM, Knotts TA, Rabasa G, Sladek JA, et al. Myelin as a regulator of development of the microbiota-gut-brain axis. Brain, Behavior, Immun. 2021;91:437–50.
CASGoogle Scholar
Wang LN, Zhang Z. [Mendelian randomization approach, used for causal inferences]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2017;38:547–52.
CASPubMedGoogle Scholar
Download references
Acknowledgements
The authors thank all investigators and participants from the groups for sharing these data.
Author information
Authors and Affiliations
Department of Psychiatry, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, 210029, China
Qian Zhao & Fuquan Zhang
School of Systems Biology, George Mason University, Fairfax, 22030, USA
Ancha Baranova & Hongbao Cao
Research Centre for Medical Genetics, Moscow, 115478, Russia
Ancha Baranova
Department of Radiology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008, China
Dongming Liu
Institute of Neuropsychiatry, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, 210029, China
Fuquan Zhang
Authors
Qian Zhao
View author publications
You can also search for this author inPubMedGoogle Scholar
2. Ancha Baranova
View author publications
You can also search for this author inPubMedGoogle Scholar
3. Dongming Liu
View author publications
You can also search for this author inPubMedGoogle Scholar
4. Hongbao Cao
View author publications
You can also search for this author inPubMedGoogle Scholar
5. Fuquan Zhang
View author publications
You can also search for this author inPubMedGoogle Scholar
Contributions
QZ: Writing – Original Draft; Writing – Review & Editing; Visualization. AB, DL, and HC: Writing – Review & Editing. FZ: Conceptualization; Formal Analysis; Supervision. All authors contributed to the revision of the manuscript. All authors approved the final version. FZ is the guarantor of this work and, as such, has full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Corresponding author
Correspondence to Fuquan Zhang.
Ethics declarations
Ethics approval and consent to participate
This study adheres to the STROBE-MR guidelines. The genome-wide association study cohorts used in this research received ethical approval, and informed consents were obtained as documented in the original studies from which these datasets were derived.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Figures
Supplementary Tables
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Reprints and permissions
About this article
Check for updates. Verify currency and authenticity via CrossMark
Cite this article
Zhao, Q., Baranova, A., Liu, D. et al. Bidirectional causal associations between plasma metabolites and bipolar disorder. Mol Psychiatry (2025). https://doi.org/10.1038/s41380-025-02977-3
Download citation
Received:24 September 2024
Revised:03 March 2025
Accepted:21 March 2025
Published:02 April 2025
DOI:https://doi.org/10.1038/s41380-025-02977-3
Share this article
Anyone you share the following link with will be able to read this content:
Get shareable link
Sorry, a shareable link is not currently available for this article.
Copy to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative